Renova Therapeutics

Transforming the lives of patients with congestive heart failure

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Website renovatherapeutics.com

Company Summary

Renova Therapeutics is developing gene therapy treatments for patients with congestive heart failure. These treatments have the potential to lower the morbidity and mortality from this terrible disease.

Team

  • Jack Reich
    CEO

    Jack W. Reich, Ph.D. (Co-founder: CEO)
    Collateral Therapeutics (CEO), Myotech, Viagene and Gensia Pharmaceuticals (VP-Regulatory and Quality)-Each of these companies went public and/or were aquired

  • Kirk Hammond
    Founder and Professor of Medicine

    H. Kirk Hammond, MD (Co-founder: CSO), Professor of Medicine-UCSD, Scientific Founder-Collateral Therapeutics, Selected by the NIH as one of five Centers of Excellence in Gene Therapy in  the USA

  • Craig Andrews
    Founder and COO

    Craig Andrews (Co-founder:COO), Partner-DLA Piper, Partner-Heller Ehrman, Partner-Brobeck Phleger and Harrison, VP-Airfiber

  • Roy Cosan
    Board Member

    Roy Cosan-30 plus years of Senior Management at J&J

  • Andy Noorda
    Board Member

    Andy Noorda- A member of a well known family responsible for the founding and development of a major public tech company

  • Jack Reich

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free